Valspar will sell the assets of its industrial wood-coatings business to satisfy US regulators’ antitrust concerns on its acquisition by Sherwin-Williams.
Valspar and Sherwin-Williams said Wednesday the unit will be sold to Philadelphia-based Axalta Coatings Systems for $420 million in cash. The Valspar wood-coatings business, with $225 million in annual revenue, is considered one of the leading providers of coatings for both original equipment manufacturers and aftermarket applications.
Sherwin-Williams announced a year ago its plans to buy Valspar for $11.3 billion. In the months that followed, regulators in the US and Canada made it clear that the deal would face antitrust obstacles and some type of division or asset divestiture would be needed.
“With this [Axalta] agreement, we believe that we have addressed regulatory concerns appropriately and we are moving forward to obtain approval for our acquisition of Valspar,” said Sherwin-Williams CEO John Morikis in a statement.
Full Content: Star Tribune
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas